ADAPTIVE BIOTECHNOLOGIES CORPORATION: cashflow_financing
| Value | {"amount": 74000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-06-30 |
| Status | current |
| Entity | ADAPTIVE BIOTECHNOLOGIES CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:40:41.432875+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ac5d0289-dbf9-4a79-9489-b6e1157c8371
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-089342Retrieved: 2026-08-19T14:40:41.432875+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001478320/cashflow-financing/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ac5d0289-dbf9-4a79-9489-b6e1157c8371
History
- no predecessors — first report